Management of the Axilla in Early-Stage Breast Cancer: OH (CCO) and ASCO Guideline
An interview with Dr. Muriel Brackstone from London Health Sciences Centre and Dr. Tari King from Dana Farber and Brigham and Women's Cancer Center, authors on "Management of the Axilla in Early-Stage Breast Cancer: OH (CCO) and ASCO Guideline." This guideline addresses management & timing of surgi…
Breast Surgical Oncology with Drs. Tari King and Monica Morrow
PrecisCa sits down with Dr. Tari King and Dr. Monica Morrow as they answer select questions about breast surgery.
Visit www.precisca.com for more resources, content, and access to our entire catalogue of educational content. There you will have access to our complete library of educational videos.…
Impact of the Histologic Pattern of Residual Tumor After Neoadjuvant Chemotherapy on Recurrence and Survival in Stage I–III Breast Cancer
Rick Greene, MD, and Tari King, MD, FSSO, discuss findings generated from central path review of a large series of patients treated with neoadjuvant chemotherapy and surgery regarding the pattern of residual tumor in the breast and its related prognostic significance. Dr. King is the senior author …
WICS Finance Series: Episode 4 - Organizational Fund Flow
Listen to the final episode of this 4-part Women in Cancer Surgery podcast series on finance hosted through SurgOnc Today®. In this episode, Dr. Melissa Hogg, a member of the Women in Cancer Surgery Committee, and Dr. Tari King, Chief of Breast Surgery at Dana-Farber Brigham Cancer Center discuss o…
Resident and Medical Student Committee: Journeys in Breast Surgical Oncology
On this episode of SurgOnc Today, Dr. Tari King and Dr. Austin Williams join Dr. Kara Button to discuss their paths into breast surgical oncology, from early training and pivotal mentorship moments to the decisions that shaped their careers. We explore how each navigated the transition from trainin…
Dr. Gregory Vidal, Dr. Pooja Advani, & Dr. Tari King - T-DXd in Early HER2+ Breast Cancer
How will DESTINY-Breast11 and DESTINY-Breast05 change the treatment of early-stage HER2-positive breast cancer?
Dr. Gregory Vidal, Dr. Pooja Advani, and Dr. Tari King discuss the landmark approvals of trastuzumab deruxtecan (T-DXd) and what they mean for medical oncologists and surgeons treating H…
PODCAST-ZOEKMACHINE
U kunt onze website gebruiken om3,833,372podcasts en197,083,803afleveringen te zoeken op mensen, plaatsen of onderwerpen.
If I have seen further than others, it is by listening to podcasts and standing upon the shoulders of
giants.
‐ Isaac "Llamacorn" Newton
BEWERKEN
Bedankt voor uw hulp bij het up-to-date te houden van de podcast-database .
